Major congenital anomalies, mental retardation or genetic disorders occur in 3-4% of all births, and represent a serious personal, family and societal health burden. While disparate etiologies for these anomalies are recognized, the cause(s) remain unknown in about 65% of cases and in close to 90% of neural tube defects (NTDs). Despite important evidence implicating environmental factors, few definitive associations have been established. This study of 25,700 pregnancies will focus on neural tube and other congenital defects, specifically seeking associations between such defects and periconceptional vitamin A and folic acid consumption, hyperthermia, antecedent spontaneous abortion, spermicides, and other environmental/genetic factors. This data, obtained by broad-based validated questionnaire, will be further correlated with results of neutron activation analysis for specified trace elements in the toenails of all women who bear progeny with a congenital anomaly (about 825, including about 70 NTDs). We plan to use a specially designed questionnaire to prospectively interview 27,500 pregnant women (about 16 wks) undergoing genetic amniocentesis. The amniotic fluid samples of these patients (= 10,000 each year) are all routinely sent for alpha-fetoprotein assay by genetic centers in 22 states to the Center for Human Genetics. Interviews will be concluded prior to completion of the diagnostic assays. Complete data on pregnancy outcome and on infants at 1 year of age (for the presence of congenital defects/developmental disorders) will be obtained. Special methodological considerations include the adequacy of study power, the generalizability of results and the various possible selection, information and confounding biases. This study is unique because (1) it is based upon a large cohort of women at high risk of bearing defective progeny studied in one center, (2) utilizes a validated questionnaire correlated with blood carotene and folate status in an initial cohort of 100 women at 2-8 wks gestation and destined for amniocentesis at 16 wks, (3) is prospective, (4) is in early pregnancy avoiding problems of both recall and subsequent recall bias, (5) of extended follow-up to a year of age, (6) analysis of nails retrospectively reflecting periconceptional trace element status. Elucidation of any causal factors could lead to the reduction in the frequency of neural tube or other congenital defects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS019561-04
Application #
3399652
Study Section
Epidemiology and Disease Control Subcommittee 3 (EDC)
Project Start
1984-07-01
Project End
1989-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Moore, Lynn L; Bradlee, M Loring; Singer, Martha R et al. (2003) Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology 14:200-5
Moore, Lynn L; Bradlee, M Loring; Singer, Martha R et al. (2002) Chromosomal anomalies among the offspring of women with gestational diabetes. Am J Epidemiol 155:719-24
Rothman, K J; Moore, L L; Singer, M R et al. (1995) Teratogenicity of high vitamin A intake. N Engl J Med 333:1369-73
Milunsky, A; Morris, J S; Jick, H et al. (1992) Maternal zinc and fetal neural tube defects. Teratology 46:341-8
Milunsky, A; Ulcickas, M; Rothman, K J et al. (1992) Maternal heat exposure and neural tube defects. JAMA 268:882-5
Milunsky, A; Jick, S S; Bruell, C L et al. (1989) Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol 161:291-7
Milunsky, A; Jick, H; Jick, S S et al. (1989) Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847-52